Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters

[1]  松角 宏一郎.  Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7 , 1996 .

[2]  K. Black,et al.  Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors , 1994, Brain Research.

[3]  K D Pettigrew,et al.  Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. , 1978, The American journal of physiology.

[4]  K. Black,et al.  Use of CereportTM (RMP-7) to Increase Delivery of Carboplatin to Gliomas: Insight and Parameters for Intracarotid Infusion Via a Single-Lumen Cannula , 1999 .

[5]  K. Miles,et al.  A simplified technique for measurement of blood-brain barrier permeability using CT: Preliminary results of the effect of RMP-7 , 1996 .

[6]  S. Rapoport,et al.  Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. , 1984, Federation proceedings.

[7]  T. Cloughesy,et al.  Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. , 1997, Journal of neurosurgery.

[8]  K. Black,et al.  Unlocking the Blood–Brain Barrier: A Role for RMP-7 in Brain Tumor Therapy , 1996, Experimental Neurology.

[9]  T. Stormann,et al.  Molecular biology and pharmacology of bradykinin receptors , 1993 .

[10]  R. Heller-Harrison,et al.  The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. , 1994, The Journal of pharmacology and experimental therapeutics.

[11]  L. M. Leeb-Lundberg,et al.  Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways. , 1992, The Journal of biological chemistry.

[12]  K. Black.  Biochemical opening of the blood-brain barrier. , 1995, Advanced drug delivery reviews.

[13]  Per Brodal,et al.  A stereotaxic atlas of the rat brain L. J. Pellegrino, A. S. Pellegrino & A. J. Cushman. Plenum Press, New York (1979). 122 Figures. £22.50 , 1980, Neuroscience.

[14]  E P Frenkel,et al.  Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. , 1984, Neurosurgery.

[15]  R. Bartus,et al.  Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7 , 1995, Brain Research.

[16]  R. Bartus,et al.  Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7. , 1996, Immunopharmacology.

[17]  R. Bartus,et al.  Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. , 1996, Cancer research.

[18]  Keith L Black,et al.  Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas , 1998, Brain Research.

[19]  J. Minna,et al.  Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. , 1985, Neurosurgery.

[20]  Y. Z. Ziylan,et al.  Effect of Dexamethasone on Transport of α‐Aminoisobutyric Acid and Sucrose Across the Blood‐Brain Barrier , 1988, Journal of neurochemistry.

[21]  P. J. Elliott,et al.  Controlled Modulation of BBB Permeability Using the Bradykinin Agonist, RMP-7 , 1996, Experimental Neurology.

[22]  K. Black,et al.  Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. , 1994, Journal of neurosurgery.

[23]  M. Fukui,et al.  Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. , 1996, Neurosurgery.

[24]  R. Bartus,et al.  Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system. , 1996, Immunopharmacology.

[25]  K. Black,et al.  Bradykinin Selectively Opens Blood-Tumor Barrier in Experimental Brain Tumors , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.